NO990436L - FremgangsmÕte for behandling av bipolar forstyrrelse - Google Patents

FremgangsmÕte for behandling av bipolar forstyrrelse

Info

Publication number
NO990436L
NO990436L NO990436A NO990436A NO990436L NO 990436 L NO990436 L NO 990436L NO 990436 A NO990436 A NO 990436A NO 990436 A NO990436 A NO 990436A NO 990436 L NO990436 L NO 990436L
Authority
NO
Norway
Prior art keywords
bipolar disorder
procedure
treatment
humans
compound
Prior art date
Application number
NO990436A
Other languages
English (en)
Norwegian (no)
Other versions
NO990436D0 (no
Inventor
Franklin Porter Bymaster
Harlan Edgar Shannon
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO990436D0 publication Critical patent/NO990436D0/no
Publication of NO990436L publication Critical patent/NO990436L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Steroid Compounds (AREA)
  • Processing Of Solid Wastes (AREA)
  • Press Drives And Press Lines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nonmetallic Welding Materials (AREA)
NO990436A 1996-08-01 1999-01-29 FremgangsmÕte for behandling av bipolar forstyrrelse NO990436L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2290096P 1996-08-01 1996-08-01
PCT/US1997/013185 WO1998005324A1 (fr) 1996-08-01 1997-07-28 Procede de traitement des maladies affectives bipolaires

Publications (2)

Publication Number Publication Date
NO990436D0 NO990436D0 (no) 1999-01-29
NO990436L true NO990436L (no) 1999-01-29

Family

ID=21812011

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990436A NO990436L (no) 1996-08-01 1999-01-29 FremgangsmÕte for behandling av bipolar forstyrrelse

Country Status (19)

Country Link
EP (1) EP0821955B1 (fr)
JP (1) JP2000515547A (fr)
KR (1) KR20000029647A (fr)
CN (1) CN1226165A (fr)
AT (1) ATE213413T1 (fr)
AU (1) AU716972B2 (fr)
BR (1) BR9710901A (fr)
CA (1) CA2261802C (fr)
CZ (1) CZ27299A3 (fr)
DE (1) DE69710526T2 (fr)
DK (1) DK0821955T3 (fr)
EA (1) EA199900174A1 (fr)
ES (1) ES2171838T3 (fr)
HU (1) HUP9904578A2 (fr)
IL (1) IL128280A0 (fr)
NO (1) NO990436L (fr)
PL (1) PL331407A1 (fr)
PT (1) PT821955E (fr)
WO (1) WO1998005324A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
EP2456868A4 (fr) 2009-07-22 2013-11-06 Puretech Ventures Procédés et compositions de traitement de troubles, ceux-ci étant améliorés par l'activation du récepteur muscarinique
WO2014078568A1 (fr) 2012-11-14 2014-05-22 The Johns Hopkins University Méthodes et compositions pour le traitement de la schizophrénie
UA128017C2 (uk) 2018-09-28 2024-03-13 Каруна Тереп'Ютікс, Інк. Композиція і спосіб лікування розладу, що послаблюється активацією мускаринових рецепторів (варіанти)
CN111430027B (zh) * 2020-03-18 2023-04-28 浙江大学 基于肠道微生物的双相情感障碍生物标志物及其筛选应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
CA2169839C (fr) * 1993-08-19 2002-06-11 Franklin Porter Bymaster Methode antipsychotique
US5821371A (en) * 1994-10-24 1998-10-13 Eli Lilly And Comany Heterocyclic compounds and their preparation and use
DK0709094T3 (da) * 1994-10-31 2000-07-10 Lilly Co Eli Tetrahydropyridinoxadiazol- eller thiadiazolforbindelse til behandling af angst
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety

Also Published As

Publication number Publication date
NO990436D0 (no) 1999-01-29
WO1998005324A1 (fr) 1998-02-12
DE69710526T2 (de) 2002-10-02
CZ27299A3 (cs) 1999-08-11
ATE213413T1 (de) 2002-03-15
IL128280A0 (en) 1999-11-30
PL331407A1 (en) 1999-07-19
EA199900174A1 (ru) 1999-08-26
EP0821955A3 (fr) 1998-04-22
AU716972B2 (en) 2000-03-09
CA2261802A1 (fr) 1998-02-12
ES2171838T3 (es) 2002-09-16
CN1226165A (zh) 1999-08-18
KR20000029647A (ko) 2000-05-25
DK0821955T3 (da) 2002-03-18
DE69710526D1 (de) 2002-03-28
CA2261802C (fr) 2006-11-07
EP0821955B1 (fr) 2002-02-20
AU4046897A (en) 1998-02-25
HUP9904578A2 (hu) 2000-06-28
JP2000515547A (ja) 2000-11-21
EP0821955A2 (fr) 1998-02-04
PT821955E (pt) 2002-07-31
BR9710901A (pt) 1999-08-17

Similar Documents

Publication Publication Date Title
EA200000220A1 (ru) Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы
ATE399547T1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und vorbeugung von neoplasia
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
EA199800667A1 (ru) Новые фенантридины
ATE218854T1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin- abhängigen protein kinase
DK0994884T3 (da) Diphosphonsyresalte til behandling af osteoporose
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
NO990436L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
BR0012921A (pt) Compostos calcilìticos
ATE283920T1 (de) Verfahren zur immunisierung und behandlung von h. pylori infektion
NO982582L (no) Fremgangsmaate for behandling av smerte
DE69736180D1 (de) Behandlung von manischen erkrankungen
EP1056458A4 (fr) Procede de traitement de la douleur, notamment de la douleur chronique et specifique aux femmes
DK0674521T3 (da) Fremgangsmåde til behandling af kronisk prostatitis med 17beta-N-tertbutylcarbamoyl-4-aza-5a-andost-1-en-3-on
NO973366L (no) Fremgangsmåte for behandling av multippel sklerose
BR9906803A (pt) Processo para tratamento de copd
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
ATE224387T1 (de) N-(pyridinylamino)isoindoline und verwandte verbindungen
NO984198L (no) FremgangsmÕte for behandling av aggresjon
DE69706195D1 (de) Antikonvulsive derivate zur behandlung von psoriasis
NO984190L (no) FremgangsmÕte for behandling av insomnia
NO985325L (no) Anvendelse av substituert azaspiran ved behandling av astma
UA25164A (uk) Спосіб оперативhого лікуваhhя косоокості по в.і. ємчеhку
UA25165A (uk) Спосіб оперативhого лікуваhhя косоокості по в.і. ємчеhку